Entellus Medical

2016 News Releases

Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
04/18/16Entellus Medical to Report First Quarter 2016 Financial Results on May 4, 2016
Conference call scheduled for Wednesday, May 4, 2016 at 3:30pm CT / 4:30pm ET PLYMOUTH, Minn., April 18, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced that it will release its financial results for the first quarter 2016 after the close of trading on Wednesday, ... 
02/24/16Entellus Medical Announces Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Financial Outlook
PLYMOUTH, Minn., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today reported its financial results for the quarter and year ended December 31, 2015.  Recent Highlights and Accomplishments Achieved net revenue of $61.6 million in 2015, an increase of 26% year-o... 
02/10/16Entellus Medical to Report Fourth Quarter and Year-End 2015 Financial Results on February 24, 2016
Conference Call Scheduled for Wednesday, February 24, 2016 at 4:30pm ET PLYMOUTH, Minn., Feb. 10, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced that it will release its financial results for the fourth quarter and year-end 2015 after the close of trading on Wedn... 
01/28/16Entellus Medical to Present at the Leerink Partners 5th Annual Global Healthcare Conference
PLYMOUTH, Minn., Jan. 28, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced the company plans to participate in the Leerink Partners 5th Annual Global Healthcare Conference in New York, NY. Entellus Medical’s management is scheduled to present on Thursday, Februar...